FDA's Newest Testosterone Update | What Men Need to Know
About this episode
Dr. Brandon and Dr. Morgentaler discuss the FDA's testosterone label changes and their implications for men with prostate cancer.
With Dr. Abraham Morgentaler and Dr. Marianne Brandon Listen to the podcast on all of your favorite platforms: Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7 Find us on: Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== Facebook: https://www.facebook.com/thesexdoctors YouTube: https://www.youtube.com/@thesexdoctorspod TikTok: https://www.tiktok.com/@thesexdoctor LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6 LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513 X (Dr. Abraham): https://x.com/DrMorgentaler X (Dr. Marianne): https://x.com/drbrandon In this episode, Dr. Brandon and Dr. Morgentaler talk about the FDA's groundbreaking testosterone label changes, the evolving evidence on testosterone therapy and prostate cancer, and how quality of life should factor into treatment decisions for men with advanced disease. 00:00 Listener Question Metastatic Prostate Cancer – Dr. Morgentaler explains whether testosterone or anabolic steroids may have a…
More episodes of The Sex Doctors
- Leading Menopause Expert Dr. Alan Altman Reveals the Truth About Hormone Therapy (Part 1)
- Interview With the President of the World's Biggest Sex Doll Company
- The Hidden Reason Some Married Men Have Affairs (From a Sex Therapist)
- The Latest Prostate Cancer Breakthroughs Explained by a Leading Urologist
- Testosterone 101: Why Normal Labs Don't Tell the Whole Story
- Can AI Replace Therapists? Here's What Experts Say
Explore listener stats, chart rankings, contacts and more on the The Sex Doctors podcast page.